Out of the 7, we highlighted 3 (Claudin 7, α- and β- catenin) whose mRNA, protein levels and/or localization are similar in cells derived from both normal and organ-confined prostate cancer but their levels and/or localization all alter in cells derived from aggressive metastatic tumours. This evidence concerns the gene CLDN7 and neoplasm.